Ads
related to: treatment of insomnia in the elderly women over 50- Efficacy Data
Read Our
Clinical Trial Data
- Safety Information
Get Details on Our
Safety Profile
- FAQs
Have a Question?
Get Answers
- Demonstrated Safety
Safety Was Evaluated In Adults
With Insomnia. Know More.
- Efficacy Data
Search results
Results From The WOW.Com Content Network
It is not advisable to prescribe somnifacients for routine insomnia treatment, and they should only be used for short periods in patients who are severely distressed or with transient insomnia. [40] An important drawback of prolonged use is that it can result in rebound insomnia and withdrawal syndrome upon discontinuation. [ 40 ]
Numerous studies have reported positive outcomes of combining cognitive behavioral therapy for insomnia treatment with treatments such as stimulus control and the relaxation therapies. Hypnotic medications are equally effective in the short-term treatment of insomnia, but their effects wear off over time due to tolerance.
Over time, insomnia can also contribute to chronic health issues like heart disease, high blood pressure, obesity, chronic pain syndrome and diabetes. What are the causes or risk factors for insomnia?
This has led to the Z-drugs becoming widely prescribed for the treatment of insomnia particularly in elderly patients. [13] [14] [15] Almost a third of all prescriptions written for Z-drugs are for adults over the age of 65. [16] Long-term use is not recommended as tolerance and addiction can occur. [17]
Women, people who work nights, and seniors are among those most at risk. It often runs in families, and recently, experts concluded that COVID-19 can trigger new insomnia.
Insomnia is one of the most common sleep disorders, with the Centers for Disease Control and Prevention reporting that as many as one in two adults experience short-term bouts, while one in 10 may ...
Ad
related to: treatment of insomnia in the elderly women over 50